Rafferty Asset Management, LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 263 filers reported holding SAGE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
Rafferty Asset Management, LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$8,476,984
+30.0%
411,904
+197.1%
0.05%
+35.1%
Q2 2023$6,519,182
-6.3%
138,647
-16.3%
0.04%
-21.3%
Q1 2023$6,954,073
+11.3%
165,731
+1.1%
0.05%
-9.6%
Q4 2022$6,249,506
-3.3%
163,857
-0.7%
0.05%
-24.6%
Q3 2022$6,460,000
+105.2%
164,953
+69.2%
0.07%
+137.9%
Q2 2022$3,148,000
-45.5%
97,462
-44.2%
0.03%
-14.7%
Q1 2022$5,778,000
-2.1%
174,548
+25.8%
0.03%
+9.7%
Q4 2021$5,903,000
+83.0%
138,756
+90.6%
0.03%
+40.9%
Q3 2021$3,225,000
+72.2%
72,793
+120.8%
0.02%
+83.3%
Q2 2021$1,873,000
-40.9%
32,974
-22.1%
0.01%
-45.5%
Q1 2021$3,168,000
+171.2%
42,328
+213.5%
0.02%
+100.0%
Q4 2020$1,168,000
-46.3%
13,502
-62.1%
0.01%
-57.7%
Q3 2020$2,176,000
+98.4%
35,603
+35.0%
0.03%
+73.3%
Q2 2020$1,097,000
-71.8%
26,379
-51.0%
0.02%
-75.0%
Q4 2019$3,886,000
-31.7%
53,837
+32.7%
0.06%
-32.6%
Q3 2019$5,690,000
+9.5%
40,561
+43.0%
0.09%
-2.2%
Q2 2019$5,195,000
-0.6%
28,372
-13.7%
0.09%
+8.3%
Q1 2019$5,227,00032,8640.08%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Integral Health Asset Management, LLC 311,000$10,294,0002.68%
Palo Alto Investors LP 851,719$28,192,0002.18%
Boxer Capital, LLC 1,094,000$36,211,0001.86%
DAFNA Capital Management LLC 180,306$5,968,0001.56%
Deep Track Capital, LP 675,000$22,343,0001.43%
Bellevue Group AG 3,052,404$101,034,0001.17%
Ikarian Capital, LLC 249,907$8,272,0001.09%
Ikarian Capital, LLC 250,000$8,275,0001.09%
Artal Group S.A. 750,000$24,825,0001.04%
SECTOR GAMMA AS 118,476$3,922,0000.85%
View complete list of SAGE THERAPEUTICS INC shareholders